Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Stem Cells (Dayton, Ohio)|November 8, 2012
Effective elimination of cancer stem cells by a novel drug combination strategyShuqiang Yuan, Feng Wang, Gang Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
New-onset prediabetes/diabetes worsens overall survival in patients with cancer: A real-world retrospective cohort studyMaci Winn, Svenja Pauleck, Stephanie Richardson, et al.
Glycoconjugate Journal|June 27, 2009
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecanHuan He, Carol L Nilsson, Mark R Emmett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Glioma-associated cancer-initiating cells induce immunosuppressionJun Wei, Jason Barr, Ling-Yuan Kong, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
VHA Practice Guideline Recommendations for Diffuse GliomasScott Kulich, Daniel Becker, Sanja Dacic, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Journal of Proteome Research|March 5, 2010
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiationHuan He, Carol L Nilsson, Mark R Emmett, et al.
Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Stem Cells (Dayton, Ohio)|November 8, 2012
Effective elimination of cancer stem cells by a novel drug combination strategyShuqiang Yuan, Feng Wang, Gang Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
New-onset prediabetes/diabetes worsens overall survival in patients with cancer: A real-world retrospective cohort studyMaci Winn, Svenja Pauleck, Stephanie Richardson, et al.
Glycoconjugate Journal|June 27, 2009
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecanHuan He, Carol L Nilsson, Mark R Emmett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Glioma-associated cancer-initiating cells induce immunosuppressionJun Wei, Jason Barr, Ling-Yuan Kong, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
VHA Practice Guideline Recommendations for Diffuse GliomasScott Kulich, Daniel Becker, Sanja Dacic, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Journal of Proteome Research|March 5, 2010
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiationHuan He, Carol L Nilsson, Mark R Emmett, et al.
Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Pageof 16